Company Overview of Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. engages in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products in the United States. The company’s products focus on women’s health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). Its products include Brisdelle, a non-hormonal therapy for vasomotor symptoms associated with menopause; Minivelle, an estrogen therapy patch for the treatment of vasomotor symptoms due to menopause and prevention of post-menopausal osteoporosis; CombiPatch, an estradiol/norethindrone acetate transdermal system to treat symptoms of hot flashes, and vaginal dryness associated with meno...
11960 SW 144th Street
Miami, FL 33186
Founded in 1987
Key Executives for Noven Pharmaceuticals, Inc.
Chief Executive Officer and Director
Chief Financial Officer, Vice President and Treasurer
Vice President of Operations
Chief Medical Officer and Executive Vice President of Product Development
Chief Scientific Officer and Vice President
Compensation as of Fiscal Year 2016.
Noven Pharmaceuticals, Inc. Key Developments
Noven Pharmaceuticals, Inc. Appoints Ralph Lipp as Vice President and Chief Scientific Officer
Oct 3 16
Noven Pharmaceuticals, Inc. announced the appointment of Ralph Lipp as the company’s new Vice President and Chief Scientific Officer. In this role, Lipp will lead all Research and Development efforts for the company’s transdermal drug delivery programs and related product development activities. Dr. Lipp will report to Jeff Mihm, Chief Executive Officer. Lipp has more than 25 years of experience in transdermals and drug delivery including 14 years at Schering A.G., where he rose to the position of Head of Pharmaceutical Development.
Noven Pharmaceuticals, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 01:40 PM
Sep 28 16
Noven Pharmaceuticals, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 01:40 PM. Venue: The Ritz-Carlton, Laguna Niguel, California, United States. Speakers: Patrick Gallagher, Vice President of Business Development.
Noven Pharmaceuticals, Inc. Appoints Jeff Mihm to Board of Directors
Sep 14 16
Noven Pharmaceuticals, Inc. has announced the appointment of Jeff Mihm to its board of directors. Mr. Mihm, who currently serves as Noven's CEO, brings extensive industry and business experience to the new, expanded role. Prior to his appointment as Noven's CEO in January 2016, Mr. Mihm most recently served as Noven's vice president, Chief Administrative Officer & General Counsel, where he oversaw Business Development, Corporate Affairs, Human Resources, Information Technology and Legal/Compliance functions. Prior to joining Noven in 2003, Mr. Mihm was a corporate attorney for more than 10 years, including as a partner in a national law firm.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|